Site Members can sign up for company wide alerts
Investigation Overview
San Diego, Jan. 10, 2012 (Shareholders Foundation) -- An investigation on behalf of investors in shares of BioSante Pharmaceuticals, Inc. (NASDAQ:BPAX) over potential securities laws violations by certain officers and directors at Bio Sante Pharmaceuticals in connection with the efficacy trial results for its LibiGel was announced. The investigation by a law firm focuses on possible c...
You must register (for free) or login to view the entire investigation.